Latest News about NVS
Recent news which mentions NVS
Could This Biosimilar Drug Candidate Be a Hit for Novartis?
October 03, 2022
From Motley Fool
Why Moderna Was a Sickly Stock Today
September 29, 2022
From Motley Fool
Is Biogen a Smart Biotech Stock to Buy Right Now?
September 29, 2022
From Motley Fool
European Drug Makers Say Higher Energy Costs Eating Margins: Report
September 27, 2022
From Benzinga
Citius Pharma Inks Clinical Collaboration For I/ONTAK Combo Regime in Solid Tumor Settings
September 23, 2022
From Benzinga
From Benzinga
7 Safe Havens All Investors Should Have Exposure to in 2022
September 22, 2022
From InvestorPlace
Novartis Unveils New Strategy Focused On US-First, Eight Blockbuster Brands
September 22, 2022
Tickers
NVS
From Benzinga
3 Highly Profitable Stocks That Are Super Cheap Right Now
September 21, 2022
From Motley Fool
From Benzinga
Novartis To Petition US Supreme Court To Uphold Patent Validity For Multiple Sclerosis Drug, Gilenya
September 21, 2022
Tickers
NVS
From Benzinga
3 Stocks That Could Rocket on Biden’s Cancer Moonshot
September 20, 2022
From InvestorPlace
5 Value Stocks In The Healthcare Sector
September 19, 2022
From Benzinga
From Benzinga
Swiss Competition Commission Investigates Novartis' Patent Use To Fend Off Competition
September 15, 2022
Tickers
NVS
From Benzinga
Novartis says authorities investigating a patent assertion
September 15, 2022
Tickers
NVS
From MarketWatch
Novartis Dodges Whistleblower Lawsuit Regarding Multiple Sclerosis Drug Kickback Claims
September 14, 2022
Tickers
NVS
From Benzinga
From Benzinga
Novartis' Cosentyx Shows To Ease Symptoms In Painful Skin Condition
September 12, 2022
Tickers
NVS
From Benzinga
5 Value Stocks In The Healthcare Sector
September 12, 2022
From Benzinga
Novartis Injects $300M In Early-Stage Biologics Research Tech
September 12, 2022
Tickers
NVS
From Benzinga
Novartis' Kisqali Adds One More Year Of Survival Benefit In Breast Cancer Setting
September 09, 2022
Tickers
NVS
From Benzinga
No Early Relief for JW Therapeutics from Cancer Wonder Drug
September 07, 2022
From Benzinga
From Benzinga
Novartis Appoints Merck Executive As Research Head
September 01, 2022
From Benzinga
From Benzinga
U.S.-China relations just got a whole lot better, boosting the prospects of these three stocks
August 28, 2022
From MarketWatch
With Sandoz Spinoff, Novartis Slams Brakes On Huntington's Trial
August 25, 2022
Tickers
NVS
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.